Leaflet NEXODAL 0.4mg / ml solution for injection / infusion

Indicated for: reversal of opioid effects

Route of administration: injectable / infusion

Substance: naloxone (opioid antagonist)

ATC: V03AB15 (Various | All other therapeutic products | Antidotes)

Naloxone is a medication used to counteract the effects of opioid overdose, including severe respiratory depression. It acts as an opioid receptor antagonist, blocking the effects of opioids on the central nervous system.

The medication is administered intravenously, intramuscularly, or subcutaneously, and its effects are rapid, usually within minutes. It is used in emergency situations to save lives in cases of opioid overdose.

Side effects may include nausea, vomiting, excessive sweating, and, in rare cases, allergic reactions. In opioid-dependent patients, it may induce withdrawal symptoms.

Consult your doctor for more information about the use of Naloxone. It is essential to have access to this medication in emergency situations if you are at risk of opioid overdose.

General data about NEXODAL 0.4mg / ml

  • Substance: naloxone
  • Date of latest medicines list: 01-03-2026
  • Product code: W53068001
  • Concentration: 0.4mg / ml
  • Pharmaceutical form: solution for injection / infusion
  • Packing volume: 1ml
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: HIKMA S.P.A. - ITALIA
  • Holder: ORPHA-DEVEL HANDELS UND VERTRIEBS GMBH - AUSTRIA
  • Number: 6064/2014/01
  • Shelf life: 3 years-after packing for marketing;after the first opening-it is used immediately

Concentrations available for naloxone

  • 0.4mg/ml
  • 1.8mg

Combinations with other substances